Côte d'Ivoire vs Tuvalu: Previously treated cases tested for RR-/MDR-TB
Côte d'Ivoire
100.0%
in 2024
Tuvalu
100.0%
in 2021
Côte d'Ivoire rank
1st
Tuvalu rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Côte d'Ivoire
- Tuvalu
How they compare
Côte d'Ivoire currently reports 100.0% against 100.0% in Tuvalu, a difference of 0.0%.
The two have swapped places 1 time across 6 shared years of data; in 2014 it was Côte d'Ivoire ahead.
Côte d'Ivoire ranks 1st and Tuvalu ranks 1st of 180 countries.
Côte d'Ivoire has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Côte d'Ivoire | Tuvalu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 85.5% | 36.8% | 48.8% | Côte d'Ivoire |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Côte d'Ivoire or Tuvalu?
- Côte d'Ivoire, at 100.0% against 100.0% in Tuvalu as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Côte d'Ivoire and Tuvalu?
- 0.0%, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Tuvalu?
- 6 years are reported by both, from 2014 to 2021.
- How do Côte d'Ivoire and Tuvalu rank globally for previously treated cases tested for rr-/mdr-tb?
- Côte d'Ivoire ranks 1st and Tuvalu ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.